Equifax Down Over 8%, on Pace for Largest Percent Decrease Since February -- Data Talk
Dow Jones2026/09/04 14:09Equifax Inc. (EFX) is currently at $172.68, down $16.42 or 8.68%
--Would be lowest close since July 31, 2026, when it closed at $172.62
--On pace for largest percent decrease since Feb. 3, 2026, when it fell 12.11%
--Currently down four of the past five days
--Down 11.15% this week; worst weekly performance since the week ending April 24, 2026, when it fell 12.10%
--Down 20.42% year-to-date
--Down 43.78% from its all-time closing high of $307.13 on Aug. 30, 2024
--Down 30.84% from 52 weeks ago (Sept. 5, 2025), when it closed at $249.67
--Down 34.18% from its 52-week closing high of $262.33 on Sept. 17, 2025
--Up 13.65% from its 52-week closing low of $151.93 on June 25, 2026
--Traded as low as $167.93; lowest intraday level since July 24, 2026, when it hit $165.55
--Down 11.19% at today's intraday low; largest intraday percent decrease since July 21, 2026, when it fell as much as 13.93%
--Third worst performer in the S&P 500 today
All data as of 10:07:44 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 04, 2026 10:09 ET (14:09 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Presents Both Danger and Opportunity! ETFs Are Strengthening, But This Data Is Alarming!
XRP Traders Target $1.90 as On-Chain Ledger Value Expands 43 Times to $4.26 Billion

Deka Immobilien sells Novotel Freiburg am Konzerthaus to IREMIS
Following Novartis, Novo Nordisk (NVO.US) terminates two cardiovascular clinical trials.
Novo Nordisk (NVO.US) has terminated two additional clinical trials of its experimental cardiovascular drug.
